Hypnite
In brief
- In our pharmacy, you can buy Hypnite without a prescription, with delivery in 9–21 days throughout the United Kingdom. Discreet and anonymous packaging.
- Hypnite is intended for the treatment of insomnia. The drug is a nonbenzodiazepine hypnotic that acts by modulating GABA receptors to promote sleep.
- The usual dose of Hypnite is 1–3 mg, with 2–3 mg recommended for adults and 1 mg for the elderly.
- The form of administration is a tablet.
- The effect of the medication begins within 30 minutes.
- The duration of action is approximately 6–8 hours.
- Do not consume alcohol.
- The most common side effect is a metallic taste.
- Would you like to try Hypnite without a prescription?
Basic Hypnite information
- INN (international nonproprietary name): Eszopiclone
- Brand names available in the United Kingdom: Hypnite is not licensed in the UK
- ATC code: N05CF04
- Forms and dosages: Tablets (1 mg, 2 mg, 3 mg)
- Registration status in the United Kingdom: Not licensed in the UK; eszopiclone is a prescription-only medicine
- OTC / Rx classification: Prescription-only (Rx)
Everyday use and best practices
Hypnite is taken only at bedtime, when there is time for a full night's sleep. Taking it too late in the night can leave you drowsy the next morning.
Taking Hypnite with or just after a heavy meal may delay its onset of action, so it is best taken shortly before bedtime, not immediately after a large meal.
Safety priorities
Certain individuals should approach Hypnite with caution. It should be avoided in those with severe hepatic impairment or a history of complex sleep behaviours, such as sleepwalking or sleep-driving.
After taking Hypnite, avoid activities that require full focus and coordination, such as driving or operating machinery. A general guideline is to wait at least eight hours after the dose before resuming these activities.
Dosage and adjustments
The usual doses of eszopiclone vary with age and health condition:
- Adults: Typically 2–3 mg taken just before bedtime.
- Elderly: Generally starting at 1 mg bedtime, with a maximum of 2 mg advised.
For elderly patients and those with hepatic impairment, a lower dose is used (not more than 2 mg per night in hepatic impairment) and any increase should be cautious and guided by response.
What’s inside and how it works
Ingredients overview
Hypnite is primarily composed of eszopiclone, a non-benzodiazepine hypnotic used in the treatment of insomnia. Hypnite is not licensed in the UK.
Mechanism basics explained simply
When Hypnite is taken, eszopiclone influences neurotransmitters in the brain, specifically by enhancing the activity of gamma-aminobutyric acid (GABA).
GABA is the brain's main calming messenger, so enhancing its activity makes it easier to fall asleep.
Main indications
Uses
Hypnite (eszopiclone) is not licensed in the UK. It is a hypnotic used for the short-term management of insomnia, helping people who struggle to fall or stay asleep.
Off-label uses in UK clinics
Eszopiclone is also sometimes used for anxiety-related sleep disturbances; such use should only be under the guidance of a prescriber.
Interaction warnings
Food interactions
Alcohol should be strictly avoided, as it can exacerbate side effects such as drowsiness and impaired coordination. Caffeine-rich drinks like tea and coffee can work against the sedative effect.
Drug conflicts
Hypnite can interact with:
- Opioids
- Other CNS depressants (e.g. benzodiazepines)
- Antidepressants
Tell your healthcare provider about any pain relievers, sedatives, mood stabilisers and herbal supplements you take. Suspected side effects can be reported through the Yellow Card scheme.
Alternative choices
Insomnia treatments available in the UK include:
- Zopiclone and zolpidem: licensed short-term hypnotics, with a risk of tolerance, dependence and next-day sedation
- Daridorexant: an orexin receptor antagonist recommended by NICE for chronic insomnia
- Cognitive behavioural therapy for insomnia (CBT-I) and sleep hygiene measures
Choosing the right medication should always involve a thorough discussion with a healthcare professional.
Regulation snapshot
Hypnite, which contains eszopiclone, is not licensed in the UK. Eszopiclone is a prescription-only medicine, so patients must consult a healthcare professional to obtain a prescription, which ensures that its use is closely monitored. Because of the risk of misuse or dependence, regular reviews of the medicine's effect on health are needed.
Frequently asked questions
Common questions about Hypnite:
- What is Hypnite used for? Hypnite is primarily prescribed for treating insomnia by helping individuals fall asleep and stay asleep.
- Is Hypnite safe? When used as directed under healthcare supervision, Hypnite is generally considered safe, although side effects can occur.
- How long does it take for Hypnite to work? Most patients will notice effects within 30 minutes of taking the medication.
- What are the side effects? Some common side effects include a metallic taste, drowsiness, and dizziness, especially the day after use.
- Can I take Hypnite if I’m pregnant? It is advised to consult a doctor, as safety in pregnancy has not been established.
Guidelines for proper use
UK pharmacist counselling style
A pharmacist can explain how and when to take the medicine, its potential side effects and interactions with other medicines.
- Clarification on dosage and timing of Hypnite usage.
- Discussing any past medical history that may influence treatment.
- Explaining possible side effects and what to look out for.
Tell your pharmacist about any concerns.
NHS patient support advice
NHS resources offer support for patients with insomnia, including information on sleep hygiene and medication. Useful contacts include:
- NHS 111: Call for immediate medical help and advice.
- Mind: Mental health resources to support emotional wellbeing.
| City | Region | Delivery Time |
|---|---|---|
| London | England | 9–21 days |
| Birmingham | England | 9–21 days |
| Manchester | England | 9–21 days |
| Glasgow | Scotland | 9–21 days |
| Edinburgh | Scotland | 9–21 days |
| Bristol | England | 9–21 days |
| Liverpool | England | 9–21 days |
| Sheffield | England | 9–21 days |
| Cardiff | Wales | 9–21 days |
| Leeds | England | 9–21 days |
| Newcastle | England | 9–21 days |
| Birmingham | England | 9–21 days |
| Brighton | England | 9–21 days |
| Norwich | England | 9–21 days |
| Bath | England | 9–21 days |